Article
Lack of association of CYP1 B1*3 polymorphism and ovarian cancer in a Caucasian population.
The International journal of biological markers - 1 Jan 2000
Cecchin E, Russo A, Campagnutta E, Martella L, Toffoli G
Abstract excerpt
CYP1B1 is the enzyme with the highest efficiency of conversion of estradiol to 4-hydroxyestradiol in humans. This metabolite has a well-known carcinogenic effect interacting with genomic DNA and has been hypothesized to be partly responsible for the role played by estrogens in ovarian cancer development. A polymorphism has been described for this enzyme causing a Leu to Val substitution in position 432...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
